Delivery Order SPE2DR25D3012-SPE2DR26F4E5B
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract, valued at $38,252.15, represents a single delivery order executed on December 2, 2025, with completion scheduled for December 3, 2025. This award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $11,571.36 under a firm fixed-price contract. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement to support federal medical supply needs, with performance to occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $7,314.49 under a firm fixed-price contract. The award was issued on December 8, 2025, with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,130.99 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,168.84 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. The contract is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $8,321.25, with completion expected by January 6, 2026. This is a firm fixed-price, non-set-aside delivery order issued under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $4,138.20 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 per container. The award represents a competitive, firm fixed-price contract with no set-aside designation and an ultimate completion date of November 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $17,223.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation, reflecting standard federal procurement practices. The contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. Performance will be executed from AmerisourceBergen's corporate office location...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E5BDelivery Order
The Defense Logistics Agency awarded a $34,947.77 delivery order to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 6, 2026, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's ability to compete openly in federal procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor vehicle valued through December 2026 that supports global military healthcare operations. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized medical commodities across multiple therapeutic domains to support military treatment facilities and other federal healthcare systems worldwide. AmerisourceBergen's extensive pharmaceutical distribution capabilities and proven track record of fulfilling federal medical procurement requirements position it as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.9k | 1/5/26 |